Camlin Fine Sciences Ltd
NSE:CAMLINFINE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Camlin Fine Sciences Ltd
Total Current Liabilities
Camlin Fine Sciences Ltd
Total Current Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Camlin Fine Sciences Ltd
NSE:CAMLINFINE
|
Total Current Liabilities
₹8.6B
|
CAGR 3-Years
5%
|
CAGR 5-Years
11%
|
CAGR 10-Years
14%
|
|
|
Navin Fluorine International Ltd
NSE:NAVINFLUOR
|
Total Current Liabilities
₹7.7B
|
CAGR 3-Years
12%
|
CAGR 5-Years
33%
|
CAGR 10-Years
N/A
|
|
|
S
|
Supreme Petrochem Ltd
NSE:SPLPETRO
|
Total Current Liabilities
₹10.6B
|
CAGR 3-Years
15%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
|
Aarti Industries Ltd
NSE:AARTIIND
|
Total Current Liabilities
₹39.8B
|
CAGR 3-Years
13%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
|
|
Asian Paints Ltd
NSE:ASIANPAINT
|
Total Current Liabilities
₹82B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
12%
|
CAGR 10-Years
8%
|
|
|
Gujarat Fluorochemicals Ltd
NSE:FLUOROCHEM
|
Total Current Liabilities
₹25.2B
|
CAGR 3-Years
10%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
Camlin Fine Sciences Ltd
Glance View
Camlin Fine Sciences Ltd. engages in the research, development, manufacture, and marketing of fine chemicals which are used as antioxidants, industrial chemicals, and aroma products. The company is headquartered in Mumbai, Maharashtra and currently employs 478 full-time employees. The company went IPO on 2015-01-20. The firm is a provider of antioxidants and shelf-life solutions, aroma ingredients, health and wellness, and performance chemicals. Its products include BHA, TBHQ and GUAIACOL BULK. The firm offers its products across various industries, including food and beverages, animal nutrition, pet food, aquaculture, bio-fuels, pharmaceuticals, dyes and pigments, petrochemicals and polymers. The company manufactures Methyl Vanillin which is sold under the Company’s brand name VanesseTM and Ethyl Vanillin, that is used in a range of applications, such as chocolates, ice creams, bakery products, incense sticks, perfumes, soaps, personal care and cosmetic products. Its performance chemicals business is involved in providing specialty chemicals, including Guaiacol, Veratrole, TBC, MEHQ, CME, HQEE, Hydroquinone and Catechol.
See Also
What is Camlin Fine Sciences Ltd's Total Current Liabilities?
Total Current Liabilities
8.6B
INR
Based on the financial report for Dec 31, 2025, Camlin Fine Sciences Ltd's Total Current Liabilities amounts to 8.6B INR.
What is Camlin Fine Sciences Ltd's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
14%
Over the last year, the Total Current Liabilities growth was 1%. The average annual Total Current Liabilities growth rates for Camlin Fine Sciences Ltd have been 5% over the past three years , 11% over the past five years , and 14% over the past ten years .
